APRE insider buying
2 cluster buysAprea Therapeutics, Inc. · Healthcare
When two or more insiders at Aprea Therapeutics, Inc. buy APRE on the open market around the same time, that clustered conviction is one of the highest-signal patterns in SEC filing data. Below is every cluster we've detected in APRE plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.
Detected clusters
- Dec 10, 2025 – Jan 30, 2026Detected Jan 30, 2026High conviction3 insidersTotal bought$61.0KMarket cap$9.3M
- Oct 10 – Oct 23, 2024Detected Oct 23, 2024High conviction5 insidersTotal bought$165.9KMarket cap$9.3M
All notable open-market buys in APRE
Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Jan 30, 2026 | Gilad Orencluster Director, President/CEO | 28,100 | $0.89 | $25.0K | SEC ↗ |
| Jan 30, 2026 | Hamill John P.cluster SrVP/CFO/Prin Fin & Acct Ofcr | 5,700 | $0.89 | $5.1K | SEC ↗ |
| Dec 10, 2025 | Duey Marccluster Director | 21,459 | $1.17 | $25.1K | SEC ↗ |
| Dec 10, 2025 | Hamill John P.cluster SrVP/CFO/Prin Fin & Acct Ofcr | 5,000 | $1.17 | $5.9K | SEC ↗ |
| Apr 3, 2025 | Director, President/CEO | 3,003 | $1.87 | $5.6K | SEC ↗ |
| Apr 3, 2025 | Director, President/CEO | 2,497 | $1.80 | $4.5K | SEC ↗ |
| Oct 23, 2024 | Gilad Orencluster Director, President/CEO | 500 | $3.92 | $2.0K | SEC ↗ |
| Oct 16, 2024 | Duey Marccluster Director | 30,000 | $4.39 | $131.7K | SEC ↗ |
| Oct 15, 2024 | Gilad Orencluster Director, President/CEO | 250 | $2.90 | $725.0 | SEC ↗ |
| Oct 14, 2024 | Gilad Orencluster Director, President/CEO | 1,000 | $2.59 | $2.6K | SEC ↗ |
| Oct 14, 2024 | Duey Marccluster Director | 190 | $2.58 | $490.2 | SEC ↗ |
| Oct 11, 2024 | Seizinger Bernd R.cluster Director | 10,000 | $2.68 | $26.8K | SEC ↗ |
| Oct 11, 2024 | Hamill John P.cluster SrVP/CFO/Prin Fin & Acct Ofcr | 50 | $2.46 | $123.0 | SEC ↗ |
| Oct 10, 2024 | Hamill John P.cluster SrVP/CFO/Prin Fin & Acct Ofcr | 450 | $2.61 | $1.2K | SEC ↗ |
| Oct 10, 2024 | Gilad Orencluster Director, President/CEO | 150 | $2.54 | $381.0 | SEC ↗ |
More Healthcare stocks with insider cluster buys
APRE insider buying — FAQ
- Are insiders buying APRE stock?
- Yes — 5 distinct insiders have bought APRE (Aprea Therapeutics, Inc.) on the open market, including 2 cluster buys where two or more insiders bought within a rolling window. The most recent qualifying activity was Feb 2, 2026.
- How much APRE stock have insiders bought?
- Insiders have bought a combined $237.1K of APRE across 15 open-market purchases, based on SEC Form 4 filings.
- What is an insider cluster buy in APRE?
- A cluster buy is two or more distinct Aprea Therapeutics, Inc. insiders — officers, directors, or 10% owners — each buying APRE on the open market within a rolling window. APRE has 2 detected cluster buys to date.
- Where does this APRE insider trading data come from?
- Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.
How we track insider buying in APRE
We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy APRE within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?
This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding APRE.